CHANNEL THERAPEUTICS CORPORATION
CHANNEL THERAPEUTICS CORPORATION is a registered legal entity registered in United States under 0451201670, and its current status with New Jersey Division of Revenue & Enterprise Services is active. The company was incorporated on 8 November 2024 and lists its registered address as FREEHOLD, United States. 5 shareholders are on record for CHANNEL THERAPEUTICS CORPORATION, and since every one of them is a company rather than an individual, this particular filing does not on its own establish an ultimate beneficial owner (UBO) — identifying one would mean tracing the ownership of each shareholding company in turn. This profile is sourced directly from New Jersey Division of Revenue & Enterprise Services and was last updated on 21 October 2026.
- Company fundamentals
- Corporate linkage & group structures
- Digitized company financials
- Firmographics — websites, social profiles, revenue and employee estimates
Shareholders
5
Five shareholders are currently on record for CHANNEL THERAPEUTICS CORPORATION, reflecting the stock ledger kept by the company under state corporate law (e.g. §219 of the Delaware General Corporation Law) rather than a public filing.
The largest of these is Ikarian Capital, LLC, holding 72.8% — a majority holding — followed by Boothbay Fund Management, LLC at 21.6%; the remaining 3 shareholders shown hold smaller stakes.
The register reports 11 shareholders in total, though only the top 5 by holding are shown in this view.
Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
| Shareholder | Type | Holding | Source Document |
|---|---|---|---|
| Ikarian Capital, LLC | 72.8% | New Jersey Division of Revenue & Enterprise Services | |
| Boothbay Fund Management, LLC | 21.6% | New Jersey Division of Revenue & Enterprise Services | |
| Wealth Enhancement Advisory Services, LLC | 1.7% | New Jersey Division of Revenue & Enterprise Services | |
| Geode Capital Management, LLC | 1.7% | New Jersey Division of Revenue & Enterprise Services | |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 1.4% | New Jersey Division of Revenue & Enterprise Services |
Officers
2
Two officers are currently on record for CHANNEL THERAPEUTICS CORPORATION, filed with New Jersey Division of Revenue & Enterprise Services. Francis Knuettel Ii, M.b.a. serves as President, Ceo, Cfo, Treasurer, Secretary & Director; Eric Lang M.d. serves as Chief Medical Officer.
Management authority at CHANNEL THERAPEUTICS CORPORATION sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
The source filing doesn't specify representation authority — whether officers can act individually or must sign jointly to bind the company — so that detail isn't available here.
Get complete shareholder and officer records, ultimate beneficial owner resolution, and ongoing ownership monitoring.
Frequently Asked Questions
Who owns CHANNEL THERAPEUTICS CORPORATION?
Five shareholders are currently on record for CHANNEL THERAPEUTICS CORPORATION, reflecting the stock ledger kept by the company under state corporate law (e.g. §219 of the Delaware General Corporation Law) rather than a public filing. The largest of these is Ikarian Capital, LLC, holding 72.8% — a majority holding — followed by Boothbay Fund Management, LLC at 21.6%; the remaining 3 shareholders shown hold smaller stakes. Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
Who is CHANNEL THERAPEUTICS CORPORATION's UBO (Ultimate Beneficial Owner)?
Every shareholder recorded for CHANNEL THERAPEUTICS CORPORATION is itself a company rather than a natural person, so no Ultimate Beneficial Owner (UBO) is identified at this level; establishing one would require tracing the ownership of each shareholding company in turn.
How many shareholders does CHANNEL THERAPEUTICS CORPORATION have on record?
5 shareholders are shown on record for CHANNEL THERAPEUTICS CORPORATION. The register reports 11 in total; only the top 5 by holding are shown here.
What is CHANNEL THERAPEUTICS CORPORATION's company registration number?
CHANNEL THERAPEUTICS CORPORATION's registration number is 0451201670, filed with New Jersey Division of Revenue & Enterprise Services in United States. Its current status on the register is active.
Is CHANNEL THERAPEUTICS CORPORATION still an active company?
CHANNEL THERAPEUTICS CORPORATION's status on New Jersey Division of Revenue & Enterprise Services is listed as active.
When was CHANNEL THERAPEUTICS CORPORATION incorporated?
CHANNEL THERAPEUTICS CORPORATION was incorporated on 8 November 2024, according to New Jersey Division of Revenue & Enterprise Services.
What is CHANNEL THERAPEUTICS CORPORATION's registered address?
The registered address on file for CHANNEL THERAPEUTICS CORPORATION is FREEHOLD, United States.
Who are the officers/directors of CHANNEL THERAPEUTICS CORPORATION?
Two officers are currently on record for CHANNEL THERAPEUTICS CORPORATION, filed with New Jersey Division of Revenue & Enterprise Services. Francis Knuettel Ii, M.b.a. serves as President, Ceo, Cfo, Treasurer, Secretary & Director; Eric Lang M.d. serves as Chief Medical Officer. Management authority at CHANNEL THERAPEUTICS CORPORATION sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
Can Zavia monitor changes to CHANNEL THERAPEUTICS CORPORATION's ownership over time?
This profile reflects a point-in-time snapshot from New Jersey Division of Revenue & Enterprise Services. Zavia's monitoring API can track changes to CHANNEL THERAPEUTICS CORPORATION's registered shareholders, officers, and group structure going forward, flagging updates as they're filed rather than requiring a manual recheck.
Can I access CHANNEL THERAPEUTICS CORPORATION's data through an API?
Yes. Zavia's API connects directly to official government ownership registries across 195 countries and territories, including United States, so records like CHANNEL THERAPEUTICS CORPORATION's registration, shareholder, UBO, and group-structure data can be queried programmatically instead of viewed one page at a time.
Where does this company information come from, and how current is it?
This record is sourced directly from New Jersey Division of Revenue & Enterprise Services and was last synced on 21 October 2026.